22 May 2013
Keywords: skyepharma, cti, submit, reformulated, zileuton, fda, uk-based
Article | 14 August 2006
UK-based drugmaker SkyePharma says that its US partner Critical Therapeutics has completed the submission of a New Drug Application to
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 August 2006
21 May 2013
© 2013 thepharmaletter.com